Related Experiment Video
Updated: May 8, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Port-a-cath-related thrombosis and postthrombotic syndrome in pediatric oncology patients
Manuela Albisetti1, Christian J Kellenberger, Eva Bergsträsser
1Division of Hematology, University Children's Hospital, Zurich, Switzerland; Children's Research Center, University Children's Hospital, Zurich, Switzerland.
Insights
Port-A-Cath (PAC) thrombosis is common in pediatric cancer patients, affecting nearly 40%. Risk factors include younger age, female sex, and longer PAC use, with some cases leading to postthrombotic syndrome (PTS).
Area of Science:
- Pediatric Oncology
- Vascular Access Devices
- Thrombosis Research
Background:
- Port-A-Cath (PAC) devices are crucial for chemotherapy delivery in pediatric cancer patients.
- Thrombosis and postthrombotic syndrome (PTS) are potential complications associated with PAC use.
- Understanding the incidence and risk factors for PAC-related thrombosis is essential for patient management.
Purpose of the Study:
- To determine the prevalence of Port-A-Cath (PAC)-related thrombosis in children undergoing cancer treatment.
- To identify risk factors associated with the development of PAC-related thrombosis.
- To assess the incidence of postthrombotic syndrome (PTS) in this pediatric cohort.
Main Methods:
- A consecutive cohort of 114 pediatric cancer patients with PACs was evaluated.
- Magnetic resonance venography was used to diagnose PAC-related thrombosis.
- Congenital prothrombotic risk factors and PTS were assessed.
Main Results:
- Nearly 40% (39.5%) of children experienced PAC-related thrombosis.
- Younger age, female sex, longer PAC duration, and left-sided placement were linked to increased thrombosis risk.
- Mild PTS was observed in 5.6% of patients.
Conclusions:
- PAC-related thrombosis is a frequent complication in pediatric oncology.
- Thrombotic events can lead to the development of PTS in some children.
- Further research may inform strategies to mitigate PAC-related thrombotic risks.
Objective:
To investigate Port-A-Cath (PAC)-related thrombosis and postthrombotic syndrome (PTS) in children with cancer.
Study Design:
The study population was a consecutive cohort of children diagnosed with cancer and a PAC implanted at diagnosis. Children were evaluated for the presence of PAC-related thrombosis by magnetic resonance venography and the presence of congenital prothrombotic risk factors and PTS.
Results:
A total of 114 children (median age, 6.04 years) were included. Of these children, 48 (42%) were treated for solid tumors and 66 (58%) were treated for hematopoietic tumors, including 38 for acute lymphoblastic leukemia. At the time of magnetic resonance venography, 42 children (37%) had the PAC still in place, and 72 (63%) had the PAC removed. Overall, PACs were in place for a total of 324.92 PAC-years. PAC-related thrombosis was detected in 45 children (39.5%) with a current or previous PAC. Of these, 21 (47%) had a solid tumor, 14 (31%) had acute lymphoblastic leukemia, and 10 (22%) had another hematopoietic tumor. Younger age at diagnosis, female sex, duration of PAC use, and left-side PAC placement were independently associated with an increased risk of thrombosis, whereas asparaginase therapy and the presence of inherited prothrombotic risk factors were not. Mild PTS (ie, presence of prominent collateral vessels in the skin) was present in 5.6% of the children.
Conclusion:
PAC-related thrombosis is common in pediatric oncology patients. In some children, thrombotic complications can lead to the development of PTS.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Venous Thrombosis I: Introduction
